KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $65.7 million.

  • Chemed's Other Accumulated Expenses rose 899.55% to $65.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.7 million, marking a year-over-year increase of 899.55%. This contributed to the annual value of $56.7 million for FY2024, which is 318.43% down from last year.
  • Latest data reveals that Chemed reported Other Accumulated Expenses of $65.7 million as of Q3 2025, which was up 899.55% from $66.9 million recorded in Q2 2025.
  • Over the past 5 years, Chemed's Other Accumulated Expenses peaked at $84.7 million during Q2 2023, and registered a low of $52.0 million during Q2 2021.
  • In the last 5 years, Chemed's Other Accumulated Expenses had a median value of $59.9 million in 2024 and averaged $61.1 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first soared by 5449.95% in 2023, then tumbled by 2928.85% in 2024.
  • Quarter analysis of 5 years shows Chemed's Other Accumulated Expenses stood at $55.9 million in 2021, then increased by 9.1% to $61.0 million in 2022, then dropped by 3.99% to $58.6 million in 2023, then decreased by 3.18% to $56.7 million in 2024, then grew by 15.93% to $65.7 million in 2025.
  • Its Other Accumulated Expenses stands at $65.7 million for Q3 2025, versus $66.9 million for Q2 2025 and $65.7 million for Q1 2025.